Sileo, FG; Bonvicini, L; Mancuso, P; Vicentini, M; Aguzzoli, L; Khalil, A; Giorgi Rossi, P
(2023)
COVID-19 incidence in women of reproductive age: a population-based study in Reggio Emilia, northern Italy.
BMC Pregnancy Childbirth, 23 (1).
p. 726.
ISSN 1471-2393
https://doi.org/10.1186/s12884-023-06044-z
SGUL Authors: Khalil, Asma
Abstract
BACKGROUND: Despite being at higher risk of severe disease and pregnancy complications, evidence on susceptibility to SARS-CoV-2 infection in pregnancy is still limited. The aim of the study is to compare the likelihood of undergoing a SARS-CoV-2 test and testing positive for COVID-19 in pregnancy and puerperium with that of the general female population of reproductive age. METHODS: This is a retrospective population-based cohort study including 117,606 women of reproductive age (March 2020-September 2021) with 6608 (5.6%) women having ≥ 1 pregnancy. Women were linked to the pregnancy registry to be classified as "non-pregnant", "pregnant", and "puerperium"; then, according to the national case-based integrated COVID-19 surveillance system, all women undergoing a SARS-CoV-2 test during the study period were identified. The Incidence Rate Ratio was calculated to compare the likelihood of being tested for SARS-CoV-2 in pregnant, puerperium and non-pregnant women among all women included. The likelihood of having a COVID-19 diagnosis was calculated using two comparators (not-pregnant women and the person-time before/after pregnancy) by means of Cox proportional hazards models, adjusting for age and with the cluster option to control standard error calculation in repeated pregnancies. Only first infection and swabs before the first one positive were included. RESULTS: The probability of being tested for SARS-CoV-2 was 4.9 (95% CI: 4.8-5.1) and 3.6 times higher (95%CI: 3.4-3.9) in pregnancy (including spontaneous miscarriages) and in the puerperium, respectively. The Hazard Ratio (HR) of covid-19 diagnosis during pregnancy vs. non-pregnancy was 1.17 (95% CI 1.03-1.33) with similar results when comparing the risk during pregnancy with that of the same women outside pregnancy (puerperium excluded), with an HR of 1.13 (95% CI 0.96-1.33); the excess decreased when excluding the test performed at admission for delivery (HR 1.08 (95%CI 0.90-1.30). In the puerperium, the HR was 0.62 (95% CI 0.41-0.92) comparing women with ≥ 1childbirth with all other women and excluding the first two weeks of puerperium. CONCLUSIONS: Women during pregnancy showed a small increase in the risk of infection, compatible with a higher likelihood of being tested. A lower probability of infection during the puerperium was observed during the entire pandemic period, suggesting likely protective behaviors which were effective in reducing their probability of infection.
Item Type: |
Article
|
Additional Information: |
© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
Keywords: |
COVID-19, Incidence, Pregnancy, Puerperium, Risk of infection, SARS-CoV-2 test, Pregnancy, Female, Humans, Male, COVID-19, SARS-CoV-2, Incidence, COVID-19 Testing, Retrospective Studies, Cohort Studies, Pregnancy Complications, Infectious, Humans, Pregnancy Complications, Infectious, Incidence, Retrospective Studies, Cohort Studies, Pregnancy, Female, Male, COVID-19, SARS-CoV-2, COVID-19 Testing, SARS-CoV-2 test, COVID-19, Pregnancy, Puerperium, Risk of infection, Incidence, 1110 Nursing, 1114 Paediatrics and Reproductive Medicine, 1117 Public Health and Health Services, Obstetrics & Reproductive Medicine |
SGUL Research Institute / Research Centre: |
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) |
Journal or Publication Title: |
BMC Pregnancy Childbirth |
ISSN: |
1471-2393 |
Language: |
eng |
Dates: |
Date | Event |
---|
13 October 2023 | Published | 3 October 2023 | Accepted |
|
Publisher License: |
Creative Commons: Attribution 4.0 |
PubMed ID: |
37833634 |
Web of Science ID: |
WOS:001086725800001 |
|
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/115897 |
Publisher's version: |
https://doi.org/10.1186/s12884-023-06044-z |
Statistics
Item downloaded times since 05 Dec 2023.
Actions (login required)
|
Edit Item |